|
|
Volumn 365, Issue 9463, 2005, Pages 914-916
|
|
Rasagiline for motor complications in Parkinson's disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BROMOCRIPTINE;
CABERGOLINE;
CATECHOL METHYLTRANSFERASE INHIBITOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENTACAPONE;
LEVODOPA;
LISURIDE;
MONOAMINE OXIDASE B INHIBITOR;
PERGOLIDE;
PLACEBO;
PRAMIPEXOLE;
RASAGILINE;
ROPINIROLE;
SELEGILINE;
TOLCAPONE;
ANTIPARKINSON AGENT;
CATECHOL DERIVATIVE;
CATECHOL METHYLTRANSFERASE;
ENZYME INHIBITOR;
INDAN DERIVATIVE;
MONOAMINE OXIDASE INHIBITOR;
CLINICAL TRIAL;
DAILY LIFE ACTIVITY;
DISEASE COURSE;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
HUMAN;
MOTOR DYSFUNCTION;
NOTE;
OUTCOMES RESEARCH;
PARKINSON DISEASE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SCORING SYSTEM;
SIDE EFFECT;
TREATMENT OUTCOME;
AGED;
DRUG ANTAGONISM;
DRUG COMBINATION;
DYSKINESIA;
MIDDLE AGED;
AGED;
ANTIPARKINSON AGENTS;
CATECHOL O-METHYLTRANSFERASE;
CATECHOLS;
DRUG THERAPY, COMBINATION;
DYSKINESIA, DRUG-INDUCED;
ENZYME INHIBITORS;
HUMANS;
INDANS;
LEVODOPA;
MIDDLE AGED;
MONOAMINE OXIDASE INHIBITORS;
PARKINSON DISEASE;
|
|
EID: 15844410562
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)71056-4 Document Type: Note |
|
Times cited : (8)
|
|
References (7)
|
